Pascal Touchon
Patrimonio netto: 743 320 $ in data 30/09/2026
Patrimonio netto: 743 320 $ in data 30/09/2026
Dr. Pascal Touchon is a Partner at Jeito Capital SASU and an Independent Director at MedinCell SA. He is on the Board of Directors at MedinCell SA and Ipsen SA. Dr. Touchon was previously employed as a Chairman by Atara Biotherapeutics, Inc. and a SVP-Global Head Cell & Gene by Novartis Oncology, Inc. He also served on the board at Dantari, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc. and Navigate BioPharma Services, Inc. He received his MBA from INSEAD and a doctorate degree from Université Toulouse III - Paul Sabatier.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2025 | 77.955 ( 0,78% ) | 662 618 $ | 30/09/2026 | |
IPSEN SA 0% | 31/12/2025 | 500 ( 0% ) | 80 702 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IPSEN | Direttore/Membro del Consiglio | 01/10/2023 |
| MEDINCELL S.A. | Direttore/Membro del Consiglio | 01/03/2025 |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/06/2025 |
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Amministratore Delegato | 09/09/2024 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Direttore/Membro del Consiglio | 01/02/2020 |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Direttore/Membro del Consiglio | - |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Direttore/Membro del Consiglio | - |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Finance |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale